West Pharmaceutical Lifts Annual Guidance After Strong GLP-1 Driven Growth In Q1

West Pharmaceutical Services, Inc. (NYSE:WST) shares surged Thursday after the company's first-quarter 2026 earnings surpassed analyst estimates.
Open original source
West Pharmaceutical Services, Inc. (NYSE:WST) shares surged Thursday after the company's first-quarter 2026 earnings surpassed analyst estimates.
Open original source